Spotlight

A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...

Apigenin is a flavonoid widely presented in fruits and vegetables, and is known to possess anti‑inflammatory, antioxidant, and anticancer properties. The present study was designed to investigate the effects of apigenin on renal...

. Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare aggressive renal malignancy associated with hereditary leiomyomatosis and RCC syndrome (HLRCC). Tumors exhibiting heterogeneous (ie, patchy) FH loss by...

In the CheckMate 9ER trial, patients with advanced renal cell carcinoma who received first-line nivolumab plus cabozantinib had significantly better progression-free survival compared with those given sunitinib. In this study,...

For a study, the researchers wanted to determine how time from diagnosis to treatment (TTI) affected viability in patients with non-metastatic non–small-cell lung cancer (NSCLC). Between 2004 and 2013, the National Cancer...

Renal masses in kidney grafts provide a difficult clinical problem, as they must balance graft function with the necessity for cancer management. Cancers in the renal graft caused by donors can be classed as either ‘donor...

Renal cell carcinoma is the third most prevalent kind of urologic cancer. Because the first symptoms are often vague and late, the phases are often advanced when detected. As compensation, the discovery of RCC by abdominal...

Following the completion of genome-wide association studies, expression quantitative trait loci (eQTL) mapping studies are the most crucial step in genomics for identifying susceptibility genes and molecular pathways implicated...